Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).
| Image |  |
|---|---|
| Description | scientific article published on 9 December 2016 |
| Author/s |
author: Lewis R. Roberts Thomas C. Smyrk Steven R Alberts Michelle R. Mahoney Joleen M Hubbard |
| Publication date | April 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |